Particle.news

Download on the App Store

Study Finds Blood-Brain Barrier Largely Intact in Key Alzheimer’s Mouse Model

Sensitive tracer measurements in Tg2576 mice showed minimal permeability, prompting researchers to urge drug delivery plans that assume an intact barrier.

Overview

  • Texas Tech University Health Sciences Center scientists reported the findings in Fluids and Barriers of the CNS, using the Tg2576 amyloid‑producing mouse line.
  • An isotopically labeled sucrose tracer combined with LC-MS/MS and laser microdissection detected extremely low brain penetration across ages and regions.
  • Tight junction proteins remained mostly preserved, including in tissue adjacent to amyloid plaques, indicating only limited, localized changes if any.
  • The results challenge assumptions of widespread BBB leakiness in Alzheimer’s models and suggest therapies must be designed to cross an intact barrier.
  • The team cautioned the findings are model-specific and plans to test rodent versions of FDA‑approved monoclonal antibodies to probe whether treatment-related microhemorrhages or swelling cause local leakage.